ODI Pharma AB (XSAT:ODI) SpecialCharges

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:ODI ODI Pharma AB XSAT:ODI
47 GF Score
Price kr2.80
GF Value kr9.66
Valuation Significantly Undervalued
View Full Analysis

What is ODI Pharma AB SpecialCharges?

Special Charges only applies to banks.

XSAT:ODI
47GF Score
ODI Pharma AB XSAT:ODI
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ODI Pharma AB (XSAT:ODI) Overvalued in 2026?

Based on GuruFocus' analysis, ODI Pharma AB stock appears to be undervalued. The current stock price of kr2.80 is trading 71% below its estimated GF Value™ of kr9.66. GuruFocus considers ODI Pharma AB to be Significantly Undervalued.

Key valuation signals for XSAT:ODI:

  • SpecialCharges:
  • GF Value™: kr9.66 vs. price of kr2.80 (71% below fair value)
  • GF Score™: 47/100

No single metric tells the full story. See the XSAT:ODI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ODI Pharma AB Business Description

Address Ostermalmstorg 1, Stockholm, SWE, 114 42
ODI Pharma AB is a provider of medicinal cannabis. It offers its products to pharmacies, specialty clinics, and hospitals.
47GF Score

Get the complete analysis for XSAT:ODI

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.80
Price
kr9.66
GF Value